Cargando…

Comparison of hierarchical EMAX and NDLM models in dose-response for early phase clinical trials

BACKGROUND: Phase II clinical trials primarily aim to find the optimal dose and investigate the relationship between dose and efficacy relative to standard of care (control). Therefore, before moving forward to a phase III confirmatory trial, the most effective dose is needed to be identified. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xiaqing, Gajewski, Byron J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370408/ https://www.ncbi.nlm.nih.gov/pubmed/32690004 http://dx.doi.org/10.1186/s12874-020-01071-2

Ejemplares similares

Stereomicroscopic Evaluation of Marginal Fit of E.Max Press and E.Max Computer-Aided Design and Computer-Assisted Manufacturing Lithium Disilicate Ceramic Crowns: An In vitro Study
por: Elrashid, Afra Hassan, et al.
Publicado: (2019)

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial
por: Maltais, F., et al.
Publicado: (2020)

Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial
por: Bjermer, Leif H., et al.
Publicado: (2021)

Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trials
por: Liu, Junhao, et al.
Publicado: (2020)

Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial
por: Kerwin, Edward M, et al.
Publicado: (2020)

Correction to: Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trials
por: Liu, Junhao, et al.
Publicado: (2020)

Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial
por: Vogelmeier, Claus F., et al.
Publicado: (2021)

Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial
por: Vogelmeier, Claus F., et al.
Publicado: (2020)

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial
por: Maltais, François, et al.
Publicado: (2019)

IPS e.max for All-Ceramic Restorations: Clinical Survival and Success Rates of Full-Coverage Crowns and Fixed Partial Dentures
por: Brandt, Silvia, et al.
Publicado: (2019)

Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients
por: Gao, Guangyi, et al.
Publicado: (2022)

Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial
por: Bjermer, Leif, et al.
Publicado: (2021)

Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression
por: Karanevich, Alex G., et al.
Publicado: (2018)

Masking a Metal Cast Post and Core Using High Opacity e.max Ceramic Coping: A Case Report
por: Alshouibi, Ehab, et al.
Publicado: (2019)

In Vitro Effect of Porcelain Firing Cycle and Different Thicknesses of IPS E.max CAD Core on Marginal Accuracy of All-Ceramic Restorations
por: Jalalian, Ezatollah, et al.
Publicado: (2015)

The effect of different geometric shapes and angles on the fracture strength of IPS e.max computer-aided designed ceramic onlays: An in vitro study
por: Chu, Jonathan, et al.
Publicado: (2018)

Effect of heat treatment and addition of 4-META to silane on microtensile bond strength of IPS e.max CAD ceramic to resin cement
por: Soleimani, Laleh, et al.
Publicado: (2019)

Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design
por: Zhang, Chuanwu, et al.
Publicado: (2017)

Evaluation of the Translucency Properties for CAD/CAM Full Ceramic Crowns Fabricated From Glass Ceramics (E.max) or High Translucency Zirconia (Lava Plus): A Clinical Study
por: Kanout, Chaza
Publicado: (2023)

Effect of Corrosive Media on the Chemical and Mechanical Resistance of IPS e.max(®) CAD Based Li(2)Si(2)O(5) Glass-Ceramics
por: Švančárková, Anna, et al.
Publicado: (2022)

Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs
por: Wang, Yu, et al.
Publicado: (2022)

Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial
por: Luke, Jason J., et al.
Publicado: (2016)

Personalized medicine enrichment design for DHA supplementation clinical trial
por: Lei, Yang, et al.
Publicado: (2017)

Hierarchical Modelling of COVID-19 Death Risk in India in the Early Phase of the Pandemic
por: Olsen, Wendy, et al.
Publicado: (2020)

Recent and Past Musical Activity Predicts Cognitive Aging Variability: Direct Comparison with General Lifestyle Activities
por: Hanna-Pladdy, Brenda, et al.
Publicado: (2012)

Adaptive designs for phase II cross-over dose-finding trials using Bayesian model averaging
por: Simpson, Sarah, et al.
Publicado: (2015)

Hierarchical Bayesian inference for ion channel screening dose-response data
por: Johnstone, Ross H, et al.
Publicado: (2017)

HINT: Hierarchical interaction network for clinical-trial-outcome predictions
por: Fu, Tianfan, et al.
Publicado: (2022)

Comparison of international guidelines for early-phase clinical trials of cellular and gene therapy products
por: Shin, Wonsuk, et al.
Publicado: (2022)

Trends in patient‐reported outcome use in early phase dose‐finding oncology trials – an analysis of ClinicalTrials.gov
por: Lai‐Kwon, Julia, et al.
Publicado: (2021)

Dose-finding designs for early-phase cancer clinical trials: a brief guidebook to theory and practice
por: Daimon, Takashi, et al.
Publicado: (2019)

Principled Decision-Making Workflow with Hierarchical Bayesian Models of High-Throughput Dose-Response Measurements
por: Ma, Eric J., et al.
Publicado: (2021)

Three-phase hierarchical model-based and hybrid inference
por: Saarela, Svetlana, et al.
Publicado: (2023)

The Successful Synchronized Orchestration of an Investigator-Initiated Multicenter Trial Using a Clinical Trial Management System and Team Approach: Design and Utility Study
por: Mudaranthakam, Dinesh Pal, et al.
Publicado: (2021)

Unifying the analysis of continuous and categorical measures of weight loss and incorporating group effect: a secondary re-analysis of a large cluster randomized clinical trial using Bayesian approach
por: Tang, Fengming, et al.
Publicado: (2022)

SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol
por: Espinasse, Aude, et al.
Publicado: (2023)

Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance
por: Yap, Christina, et al.
Publicado: (2023)

Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol
por: Carlson, Susan E., et al.
Publicado: (2017)

Accelerating Cancer Patient Recruitment Through a Mobile Application (Clinical Trial Finder)
por: Mudaranthakam, Dinesh Pal, et al.
Publicado: (2022)

Dose Escalation Methods in Phase I Cancer Clinical Trials
por: Le Tourneau, Christophe, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3rr8bqcnb0i18tknovngi91p8f